BioNTech's updated COVID-19 vaccine on Tuesday, marking its third authorization of vaccine formulations that protect against ...

Pfizer Canada says Health Canada has approved its updated COVID-19 vaccine that protects against one of the most recently ...

Pfizer-BioNTech's updated vaccine to protect against a recently circulating variant of COVID-19 is authorized, Health Canada ...

The mRNA vaccine, called Comirnaty, targets the KP.2 subvariant of Omicron, replacing the previous version which targeted the ...

The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and olderData demonstrate that the Omicron KP.2-adapted COVID ...

It’s been over four years since the beginning of the COVID-19 pandemic. And since then, the virus has changed substantially.

In Australia, our process differs slightly and tends to take a little longer. The TGA’s website indicates applications for ...

First, the company's COVID-19 revenue has fallen like a brick. Worldwide sales for Pfizer's Comirnaty, the first COVID-19 vaccine to win approval in the U.S., plunged 87% year over year in the ...